Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Maureen T. Kelly"'
Autor:
James C. Stolzenbach, Aditya Lele, Maureen T. Kelly, Debra L. Weinstein, Laura A. Williams, Carolyn M. Setze, Dawn M. Carlson, Kim M. Burns
Publikováno v:
Clinical Therapeutics. 35:1186-1198
Patients with chronic kidney disease (CKD) often have mixed dyslipidemia and high cardiovascular disease risk. Although statins reduce LDL-C, adding a fibrate may further improve lipid parameters.This multicenter, randomized study evaluated the short
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::392f69f12549442f9ad2dc1004a618ea
https://doi.org/10.1016/j.clinthera.2013.06.013
https://doi.org/10.1016/j.clinthera.2013.06.013
Autor:
Aditya Lele, Maureen T. Kelly, Robert S. Rosenson, Michael H. Davidson, Peter B. Jones, Kamlesh M. Thakker, Eli M. Roth, Carolyn M. Setze
Publikováno v:
Journal of Clinical Lipidology. 6:534-544
Goal/desirable lipid levels are underachieved in patients with mixed dyslipidemia. These patients may have substantial residual risk of cardiovascular disease even while receiving optimal LDL-C-lowering therapy and may require additional therapy to i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b5cd906ef8cdda922de4ace4a03d1e9
https://doi.org/10.1016/j.jacl.2012.02.002
https://doi.org/10.1016/j.jacl.2012.02.002
Publikováno v:
American Journal Cardiovascular Drugs. 12:117-125
Statins are the standard-of-care therapy for reducing low-density lipoprotein cholesterol (LDL-C) levels; however, combination with other lipid-modifying agents may be necessary to normalize lipid profiles in patients with mixed dyslipidemia who, in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d0673ebe6ff998ae03742e6d4b7c625
https://doi.org/10.2165/11597940-000000000-00000
https://doi.org/10.2165/11597940-000000000-00000
Publikováno v:
Current Medical Research and Opinion. 27:1067-1078
To evaluate the achievement of individual and combined lipid and lipoprotein/biomarker targets as specified by treatment guidelines with the combination of fenofibric acid and statin therapy in patients with mixed dyslipidemia.Data for the post hoc a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b88b3c70b234c0a672606d4a6fbab14f
https://doi.org/10.1185/03007995.2011.569018
https://doi.org/10.1185/03007995.2011.569018
Autor:
Kamlesh M. Thakker, Aditya Lele, Anne C. Goldberg, Vera Bittner, Carolyn M. Setze, Darryl J. Sleep, Maureen T. Kelly, Carl J. Pepine
Publikováno v:
The American Journal of Cardiology. 107:898-905
The combination of fibrate and statin therapies may be a treatment option for women with multiple lipid abnormalities. We, therefore, initiated the present safety and efficacy analysis to address the paucity of such data in women with mixed dyslipide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7b36aed2a0df34cfc6c8b8d59ae83a5
https://doi.org/10.1016/j.amjcard.2010.11.009
https://doi.org/10.1016/j.amjcard.2010.11.009
Autor:
Aditya Lele, Maureen T. Kelly, Christie M. Ballantyne, Carolyn M. Setze, Kamlesh M. Thakker, James C. Stolzenbach, Peter B. Jones
Publikováno v:
Cardiovascular Drugs and Therapy
Objective The objective of this study was to evaluate the long-term efficacy of adding fenofibric acid to moderate-dose statin therapy in patients at goal for low-density lipoprotein cholesterol (LDL-C) but with persistent hypertriglyceridemia. Metho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42bced573b3b0ca00c149e022010dd0f
http://europepmc.org/articles/PMC3070075
http://europepmc.org/articles/PMC3070075
Autor:
Maureen T. Kelly, Peter B. Jones, James C. Stolzenbach, Carolyn M. Setze, Howard R. Knapp, Anne C. Goldberg, Darryl J. Sleep
Publikováno v:
American Heart Journal. 160:759-766
Statin and ezetimibe combination therapy may be insufficient to improve lipid and nonlipid parameters beyond low-density lipoprotein cholesterol (LDL-C) in patients with mixed dyslipidemia.In this phase 3, multicenter, double-blind study, a total of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15f5984c9674b2d26235730f1b86b650
https://doi.org/10.1016/j.ahj.2010.06.045
https://doi.org/10.1016/j.ahj.2010.06.045
Autor:
James M. McKenney, Carolyn M. Setze, Harold E. Bays, Katie Obermeyer, Darryl J. Sleep, Kamlesh M. Thakker, Eli M. Roth, Maureen T. Kelly
Publikováno v:
Diabetes Care
OBJECTIVE To compare fenofibric acid (FA) + statin to respective monotherapies on the prevalence of metabolic syndrome and its diagnostic components in patients with mixed dyslipidemia. RESEARCH DESIGN AND METHODS Post hoc analysis of over 2,000 meta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f049b9ab5762735e42dd32f09ab5707
https://doi.org/10.2337/dc10-0357
https://doi.org/10.2337/dc10-0357
Autor:
Maureen T. Kelly, Carolyn M. Setze, James M. McKenney, James C. Stolzenbach, Peter B. Jones, Laura A. Williams, Eli M. Roth, Alex Gold, Dawn M. Carlson
Publikováno v:
American Journal Cardiovascular Drugs. 10:175-186
To evaluate the efficacy and safety of fixed-dose combinations of rosuvastatin and fenofibric acid (rosuvastatin/fenofibric acid) compared with simvastatin in patients with high levels of low-density lipoprotein cholesterol (LDL-C) and triglycerides
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e6ca90643acfdf084912171682b7b1e
https://doi.org/10.2165/11533430-000000000-00000
https://doi.org/10.2165/11533430-000000000-00000
Autor:
Carolyn M. Setze, James C. Stolzenbach, Maureen T. Kelly, Kamlesh Thakker, Kenneth Cusi, Michael H. Davidson, Darryl J. Sleep, Peter B. Jones
Publikováno v:
American Journal Cardiovascular Drugs. 10:73-84
Monotherapy with lipid-modifying medication is frequently insufficient to normalize lipid abnormalities in patients with mixed dyslipidemia and type 2 diabetes mellitus.To evaluate the efficacy and safety of fenofibric acid + statin combination thera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2bfc1f651a7096aee8a6c26b2b3e015
https://doi.org/10.2165/10061630-000000000-00000
https://doi.org/10.2165/10061630-000000000-00000